Introduction
Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analogue of the endogenous tetrapeptide tuftsin, extended with a proline-glycine-proline sequence to enhance stability. Selank has been studied primarily for its anxiolytic, nootropic, and immunomodulatory properties in preclinical and clinical research conducted largely in Russia and Eastern Europe.
What Is Selank?
Selank (TBIO) consists of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is a stable analogue of tuftsin, a naturally occurring tetrapeptide with immunomodulatory and neuropeptide properties. The additional Pro-Gly-Pro sequence in Selank provides resistance to enzymatic degradation, extending its biological activity window compared to tuftsin.
Mechanism of Action
Selank appears to exert its effects through multiple mechanisms. Research suggests it modulates GABAergic transmission, which may underlie its anxiolytic properties. It has also been shown to influence the expression of brain-derived neurotrophic factor (BDNF) and to affect serotonin transporter activity. Additionally, Selank has demonstrated interactions with the enkephalinase enzyme system, potentially extending the activity of endogenous opioid peptides.
Anxiolytic Research
Animal model studies have consistently demonstrated anxiolytic effects of Selank in standard anxiety paradigms including the elevated plus maze, light-dark box, and open field tests. Clinical studies conducted in Russia have reported anxiolytic effects comparable to benzodiazepines in some anxiety disorder models, but without the sedation, dependence, or cognitive impairment associated with benzodiazepine use. These findings have driven significant interest in Selank as a research tool for GABA system and anxiety pathway investigation.
Nootropic and Cognitive Research
Selank has been studied for cognitive-enhancing properties in animal models, with research showing improved learning and memory performance in maze studies. Proposed mechanisms include BDNF upregulation and modulation of neurotransmitter systems involved in memory consolidation. Some Russian clinical research has reported enhanced cognitive performance in human subjects under conditions of stress.
Immunomodulatory Properties
As a tuftsin analogue, Selank retains immunomodulatory properties. Research has shown effects on cytokine expression, natural killer cell activity, and T-cell function in animal models. This immunological dimension of Selank’s activity distinguishes it from most other nootropic peptides and has generated independent research interest.
Stability and Administration
Selank is notable for its relatively good stability compared to many neuropeptides. It is available as a lyophilized powder for reconstitution. Intranasal administration has been used in clinical research due to the potential for direct CNS delivery through the olfactory pathway.
Conclusion
Selank is a well-studied peptide with a distinct research profile spanning anxiolytic, nootropic, and immunomodulatory activity. Its clinical research base — though primarily from Eastern European institutions — provides a more substantial human data foundation than most research peptides. It remains an important compound for researchers studying anxiety pathways, cognition, and neuropeptide pharmacology.